Special Needs LASA Paper 2017 Rubric: Your Topic Is Sclerode

Special Needs LASA Paper 2017 Rubricyour Topic Is Sclerodermaassignme

Develop a comprehensive academic paper on scleroderma, including a definition, importance of understanding the disease, its impact on oral health, signs and symptoms, risk factors, medical management including medications and side effects, dental appointment management such as emergency plans and treatment modifications, oral manifestations, barriers to care, and how critical thinking skills are used to manage patient care. Incorporate clinical examples and discuss how the knowledge gained enhances clinical preparedness.

Paper For Above instruction

Scleroderma, also known as systemic sclerosis, is a complex autoimmune connective tissue disease characterized by the excessive accumulation of collagen, leading to hardening and tightening of the skin and connective tissues. It is a rare condition with significant implications for multiple organ systems, including the skin, blood vessels, gastrointestinal tract, lungs, kidneys, and heart. Understanding scleroderma is crucial for healthcare professionals, especially those in dental and oral health fields, due to its diverse manifestations and the potential impact on oral tissues and overall health.

The importance of understanding scleroderma lies in its potential to cause severe morbidity if not managed appropriately. Oral health is particularly affected, with patients often presenting with microstomia (reduced mouth opening), periodontal disease, resorption of jaw bones, xerostomia, and esophageal reflux, all of which complicate dental care. Dental professionals must recognize these manifestations and adjust their management strategies accordingly to provide safe and effective care while addressing the unique barriers faced by these patients.

Scleroderma presents with a variety of signs and symptoms, including skin thickening, Raynaud's phenomenon, digital ulcers, joint stiffness, and pulmonary fibrosis. Risk factors include genetic predispositions, environmental triggers such as silica or organic solvents, and certain infectious agents. The disease course varies, with some patients experiencing rapid progression, while others have a more indolent form. The pathophysiology involves immune activation, vascular damage, and fibroblast overactivity, resulting in collagen overproduction.

Medically, management involves immunosuppressive therapy, vasodilators, corticosteroids, and specific drugs aimed at organ protection. Common medications such as methotrexate, cyclophosphamide, and calcium channel blockers have side effects including immunosuppression, gastrointestinal disturbances, and cardiovascular effects. These medications can influence oral health by causing dry mouth, increased susceptibility to infections, or mucosal changes. Understanding these effects is vital for dental care planning.

Dental appointment management must incorporate emergency plans and treatment modifications. For instance, microstomia limits access to oral structures, making examination and treatment challenging. Strategies include using smaller instruments, rubber dams, and mindful positioning. Patients might have increased risk of periodontal disease, so meticulous oral hygiene instructions and regular maintenance are essential. Barrier considerations, such as difficulty with standard anesthesia techniques or bleeding tendencies, must also be addressed. Collaboration with medical teams is often necessary to coordinate care, especially regarding medication management and avoiding adverse drug interactions.

An example from clinical practice involves a patient with scleroderma presenting with limited mouth opening and xerostomia. The clinical team used a customized approach involving topical fluoride, antimicrobial rinses, and modified instrumentation to manage periodontal disease effectively. Critical thinking was employed to balance the urgency of dental treatment with the risks posed by their systemic condition, highlighting the importance of patient-specific adaptations.

In conclusion, a thorough understanding of scleroderma enhances a clinician’s ability to provide safe and effective care. Recognizing the disease’s signs, symptoms, and management challenges enables dental professionals to anticipate complications and implement appropriate modifications. Educating oneself continually and applying critical thinking are essential skills in managing complex systemic diseases, ultimately improving patient outcomes and demonstrating professional preparedness.

References

• Akira, H., & Kawanami, S. (2019). Oral manifestations in systemic sclerosis and their management. Journal of Oral & Maxillofacial Research, 10(1), 17-23.
• Barnes, C., & Abraham, R. (2020). Clinical considerations in managing oral health in systemic sclerosis patients. Dental Clinics of North America, 64(2), 357-373.
• Czirják, Á., & Czirják, G. (2017). Scleroderma: A comprehensive review and perspectives. Autoimmunity Reviews, 16(7), 829-843.
• Furst, D. E. (2018). Advances in understanding systemic sclerosis. Rheumatology International, 38(4), 537-544.
• Huang, L., & Shetty, N. (2021). Oral health challenges in systemic sclerosis: A review. Journal of Oral and Maxillofacial Surgery, 79(4), 743-751.
• LeRoy, E. C., & Hughes, G. R. V. (2014). Systemic sclerosis. (Autoimmune diseases). In: Hochberg MC, et al., editors. Rheumatology (6th ed). Elsevier Saunders.
• Mehta, B., & Varga, J. (2019). Pathogenesis of systemic sclerosis: Integrating immunology, vascular biology, and fibrosis. Nature Reviews Rheumatology, 15(12), 739-748.
• Offenbacher, S., & Tomar, S. (2017). Oral health and systemic disease: An overview. Dental Clinics of North America, 61(4), 789-802.
• Ramos, M. S., & Mota, A. (2020). Managing oral manifestations in systemic sclerosis patients. Journal of Clinical Dentistry, 31(2), 45-50.
• Varga, J., & Abraham, D. (2019). Systemic sclerosis: Recent advances in pathogenesis. Current Opinion in Rheumatology, 31(6), 600-607.